← Open Payments lookup

PAULA GASTON: Open Payments

NPI 1720363344 · PARIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$675 in 26 payments from 10 companies in 2025. Trend: 2023 $484 · 2024 $249 · 2025 $675

Food & beverage: $675
CompanyPaymentsAmount
ABBVIE INC.6$191
Novo Nordisk Inc1$113
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$109
Janssen Biotech, Inc.3$67
Lilly USA, LLC3$57
IDORSIA PHARMACEUTICALS US INC2$40
Xeris Pharmaceuticals, Inc.2$35
Astellas Pharma US Inc1$23
PFIZER INC.1$21
GlaxoSmithKline, LLC.1$20

Products named: VRAYLAR, Ozempic, CAPLYTA, MOUNJARO, Quviviq, TECVAYLI, KEVEYIS, DARZALEX.

Industry payments across TX — which companies pay providers there.